Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants
Launched by PUBLIC HEALTH ENGLAND · Sep 27, 2016
Trial Information
Current as of April 26, 2025
Withdrawn
Keywords
ClinConnect Summary
The UK Department of Health provides a routine vaccination schedule for children in the UK which is administered by GP surgeries. The schedule is updated by the addition of antigens and amendment of products and schedules over time to improve the protection afforded to the paediatric population and the overall cost-effectiveness of the programme.
It is now well established that the effects of giving different vaccines and antigens together, as well as the order and numbers of doses given for priming and boosting, can affect the immunological responses they elicit. For example co-administra...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants due to receive their primary immunisations , aged up to 13 weeks on first vaccinations.
- • Written informed consent given by mother who is aged ≥\>= 16 years \[NB mother is preferable as consent also allows permission to record the date of pertussis immunisation in pregnancy, which may need to be verified in her medical record. Where mother is not available, consent may be taken from father or legal guardian and maternal pertussis status noted as not known\]
- Exclusion Criteria:
- • Bleeding disorder
- • Fulfil any of the contraindications to vaccination as specified in The Green Book \[https://www.gov.uk/government/organisations/public-health-england/series/immunisation-against-infectious-disease-the-green-book\]
About Public Health England
Public Health England (PHE) is an executive agency of the UK Department of Health and Social Care, dedicated to protecting and improving the nation's health and well-being. As a leading sponsor of clinical trials, PHE focuses on generating robust evidence to inform public health policy and practice. The organization emphasizes the importance of research in addressing health inequalities and enhancing disease prevention strategies. Through collaboration with academic institutions, healthcare providers, and industry partners, PHE drives innovative research initiatives aimed at advancing public health outcomes across diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Hertfordshire, , United Kingdom
Patients applied
Trial Officials
Elizabeth Coates, PhD
Study Chair
Public Health England
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials